Illumina Inc. (ILMN) 141.62 $ILMN
Illumina Falls 1.52% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Jun 09, 2:23PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $142.73 to a high of $146.11. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $143.52 on volume of 391,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 141.62 (-1.80)
Look for Shares of Illumina to Potentially Rebound after Yesterday's 1.52% Sell Off
Comtex SmarTrend(R) - Thu Jun 09, 2:21PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $142.73 to a high of $146.11. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $143.52 on volume of 391,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 141.62 (-1.80)
How These Biotech's Stocks are Performing? - Clovis Oncology, Illumina, NewLink Genetics and Zafgen
PR Newswire - Thu Jun 09, 7:00AM CDT
Some of the biggest opportunities in the equities market are found in tumultuous industries such as Biotechnology. The segment continues to present a number of remarkable trades as well as potentially good investment that are waiting to be discovered. This morning ActiveWallSt.com features these four biotech stocks in its technical alerts service: Clovis Oncology Inc. (NASDAQ: CLVS), Illumina Inc. (NASDAQ: ILMN), NewLink Genetics Corp. (NASDAQ: NLNK), and Zafgen Inc. (NASDAQ: ZFGN). Learn more about these stocks and receive your complimentary trade alerts at:
ZFGN: 6.39 (-0.20), CLVS: 14.11 (-1.12), NLNK: 11.29 (-0.39), ILMN: 141.62 (-1.80)
Stock Market News for June 08, 2016
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:10AM CDT
Benchmarks closed mostly in the green on Tuesday following gains in energy stocks
BIIB: 246.13 (-4.33), VRTX: 91.49 (-1.00), PXD: 159.55 (-4.65), ALXN: 135.61 (-2.63), HAL: 44.38 (-1.12), EOG: 81.56 (-3.02), AMGN: 154.78 (-2.00), ILMN: 141.62 (-1.80), XOM: 89.98 (-0.69), COP: 44.51 (-2.06), JUNO: 42.98 (-2.55), CVX: 101.98 (-0.83), OXY: 75.45 (-0.15), REGN: 372.03 (-9.05)
InvestorsObserver releases covered-call reports for SolarCity, Illumina, Nabors Industries, Amazon.com and Salesforce.com
PR Newswire - Tue Jun 07, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for SCTY, ILMN, NBR, AMZN and CRM.
AMZN: 717.91 (-9.74), SCTY: 21.23 (-1.43), NBR: 10.37 (-0.37), ILMN: 141.62 (-1.80), CRM: 81.83 (-0.90)
Alexandria Real Estate Equities, Inc. Announces Key Second Quarter 2016 Deliveries from Highly Leased Value-Creation Pipeline and Significant Projected Fourth Quarter 2016 Deliveries
PR Newswire - Tue Jun 07, 7:30AM CDT
Alexandria Real Estate Equities, Inc. (NYSE: ARE), a real estate investment trust uniquely focused on world-class collaborative science and technology campuses in urban innovation clusters, today announced the early delivery of a ground-up development of 295,609 rentable square feet (RSF) at 5200 Illumina Way, Building 6, to Illumina, Inc. in San Diego's University Town Center (UTC) submarket.
ARE: 98.60 (+0.44), ILMN: 141.62 (-1.80)
Illumina Announces Donald Danforth Plant Science Center to Receive Agricultural Greater Good Initiative Grant to Improve Food Security in Sub-Saharan Africa
BusinessWire - Tue Jun 07, 5:00AM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced that the Donald Danforth Plant Science Center is the 2016 recipient of the Agricultural Greater Good Initiative grant. Their project aims to optimize breeding strategies for improving the yield and stress tolerance of grain sorghum (Sorghum bicolor), a critical source of nutrition to millions of people living in Sub-Saharan Africa. The Illumina Agricultural Greater Good Initiative grant program is designed to help identify measures that can increase crop yields and improve livestock welfare and productivity to alleviate poverty and hunger in the developing world.
ILMN: 141.62 (-1.80)
ArcherDX Partners With Illumina to Bring Leading Fusion Oncology Assays to Global Markets
ACCESSWIRE - Mon Jun 06, 11:50AM CDT
Illumina Is Now Distributing Archer FusionPlex NGS Assays by ArcherDX Outside the USA
ILMN: 141.62 (-1.80)
Illumina Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa
BusinessWire - Thu Jun 02, 2:05AM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced that it has appointed Paula Dowdy to lead the Europe, Middle East and Africa (EMEA) commercial team as Senior Vice President and General Manager. Paula was previously Senior Vice President for Cloud, Software, and Managed Services at Cisco.
ILMN: 141.62 (-1.80)
ArcherDX to Collaborate With Illumina on Next-Generation Sequencing Based in Vitro Diagnostics Development
ACCESSWIRE - Tue May 31, 3:57PM CDT
ArcherDX and Illumina will work together to develop and bring multiple Archer® NGS-based IVD assays through the FDA approval process
ILMN: 141.62 (-1.80)
ArcherDX to Collaborate with Illumina on Next-Generation Sequencing-Based In Vitro Diagnostics Development
BusinessWire - Tue May 31, 5:51AM CDT
ArcherDX, Inc. today announced an agreement to develop next-generation sequencing (NGS)-based in vitro diagnostic (IVD) tests with Illumina, Inc. (NASDAQ: ILMN). Under terms of the agreement, ArcherDX will lead the development of a series of diagnostic tests utilizing ArcherDX's Anchored Multiplex PCR (AMP(TM)) chemistry that will be run on the Illumina(R) MiSeqDx(R) instrument. This agreement reflects the commitment of both companies to provide NGS-based diagnostics to support current and future clinical trials.
ILMN: 141.62 (-1.80)
New Strong Sell Stocks for May 26th
Swarup Gupta - Zacks Investment Research - Thu May 26, 9:27AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
CRMT: 24.14 (-0.31), BPY: 24.34 (-0.15), ILMN: 141.62 (-1.80), DXPE: 14.03 (-0.41)
Illumina to Webcast Live Presentation at Upcoming Investment Conferences in June
BusinessWire - Wed May 25, 5:30AM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentation at two upcoming investment conferences.
ILMN: 141.62 (-1.80)
SmarTrend Watching for Potential Rebound in Shares of Illumina After 1.43% Loss
Comtex SmarTrend(R) - Thu May 12, 1:57PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $136.15 to a high of $140.15. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $138.64 on volume of 471,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 141.62 (-1.80)
Illumina: Q1 Results Hit by Soaring Costs; '16 View Down
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:28AM CDT
Illumina (ILMN) made a disappointing start to first-quarter 2016 with its top and bottom lines lagging the Zacks Consensus Estimate.
SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06), ILMN: 141.62 (-1.80)
Illumina Registers MiSeqDx System in South Korea
BusinessWire - Mon May 09, 3:05PM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced it has received a product approval certificate for the MiSeqDx(R) Instrument and the MiSeqDx Universal Kit with the Ministry of Food and Drug Safety (MFDS) in South Korea. This successful approval of an Illumina next-generation sequencing (NGS) system is the first step in completing a comprehensive regulatory strategy in the APAC region.
ILMN: 141.62 (-1.80)
Collaborative Study of Whole Exome Sequencing Offers New Hope for Children with White Matter Disorders
BusinessWire - Mon May 09, 7:41AM CDT
Illumina, Inc. (NASDAQ: ILMN), Children's National Health System and The University of Queensland (UQ) announced today that a study using whole exome sequencing (WES), a method to look at all the genes in the genome at once, yielded clinical diagnoses for 42 percent of patients with white matter abnormalities that had been unresolved an average of eight years.
ILMN: 141.62 (-1.80)
Illumina Falls 1.52% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Jun 09, 2:23PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $142.73 to a high of $146.11. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $143.52 on volume of 391,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 141.62 (-1.80)
Look for Shares of Illumina to Potentially Rebound after Yesterday's 1.52% Sell Off
Comtex SmarTrend(R) - Thu Jun 09, 2:21PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $142.73 to a high of $146.11. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $143.52 on volume of 391,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 141.62 (-1.80)
How These Biotech's Stocks are Performing? - Clovis Oncology, Illumina, NewLink Genetics and Zafgen
PR Newswire - Thu Jun 09, 7:00AM CDT
Some of the biggest opportunities in the equities market are found in tumultuous industries such as Biotechnology. The segment continues to present a number of remarkable trades as well as potentially good investment that are waiting to be discovered. This morning ActiveWallSt.com features these four biotech stocks in its technical alerts service: Clovis Oncology Inc. (NASDAQ: CLVS), Illumina Inc. (NASDAQ: ILMN), NewLink Genetics Corp. (NASDAQ: NLNK), and Zafgen Inc. (NASDAQ: ZFGN). Learn more about these stocks and receive your complimentary trade alerts at:
ZFGN: 6.39 (-0.20), CLVS: 14.11 (-1.12), NLNK: 11.29 (-0.39), ILMN: 141.62 (-1.80)
Stock Market News for June 08, 2016
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:10AM CDT
Benchmarks closed mostly in the green on Tuesday following gains in energy stocks
BIIB: 246.13 (-4.33), VRTX: 91.49 (-1.00), PXD: 159.55 (-4.65), ALXN: 135.61 (-2.63), HAL: 44.38 (-1.12), EOG: 81.56 (-3.02), AMGN: 154.78 (-2.00), ILMN: 141.62 (-1.80), XOM: 89.98 (-0.69), COP: 44.51 (-2.06), JUNO: 42.98 (-2.55), CVX: 101.98 (-0.83), OXY: 75.45 (-0.15), REGN: 372.03 (-9.05)
InvestorsObserver releases covered-call reports for SolarCity, Illumina, Nabors Industries, Amazon.com and Salesforce.com
PR Newswire - Tue Jun 07, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for SCTY, ILMN, NBR, AMZN and CRM.
AMZN: 717.91 (-9.74), SCTY: 21.23 (-1.43), NBR: 10.37 (-0.37), ILMN: 141.62 (-1.80), CRM: 81.83 (-0.90)
Alexandria Real Estate Equities, Inc. Announces Key Second Quarter 2016 Deliveries from Highly Leased Value-Creation Pipeline and Significant Projected Fourth Quarter 2016 Deliveries
PR Newswire - Tue Jun 07, 7:30AM CDT
Alexandria Real Estate Equities, Inc. (NYSE: ARE), a real estate investment trust uniquely focused on world-class collaborative science and technology campuses in urban innovation clusters, today announced the early delivery of a ground-up development of 295,609 rentable square feet (RSF) at 5200 Illumina Way, Building 6, to Illumina, Inc. in San Diego's University Town Center (UTC) submarket.
ARE: 98.60 (+0.44), ILMN: 141.62 (-1.80)
Illumina Announces Donald Danforth Plant Science Center to Receive Agricultural Greater Good Initiative Grant to Improve Food Security in Sub-Saharan Africa
BusinessWire - Tue Jun 07, 5:00AM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced that the Donald Danforth Plant Science Center is the 2016 recipient of the Agricultural Greater Good Initiative grant. Their project aims to optimize breeding strategies for improving the yield and stress tolerance of grain sorghum (Sorghum bicolor), a critical source of nutrition to millions of people living in Sub-Saharan Africa. The Illumina Agricultural Greater Good Initiative grant program is designed to help identify measures that can increase crop yields and improve livestock welfare and productivity to alleviate poverty and hunger in the developing world.
ILMN: 141.62 (-1.80)
ArcherDX Partners With Illumina to Bring Leading Fusion Oncology Assays to Global Markets
ACCESSWIRE - Mon Jun 06, 11:50AM CDT
Illumina Is Now Distributing Archer FusionPlex NGS Assays by ArcherDX Outside the USA
ILMN: 141.62 (-1.80)
Illumina Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa
BusinessWire - Thu Jun 02, 2:05AM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced that it has appointed Paula Dowdy to lead the Europe, Middle East and Africa (EMEA) commercial team as Senior Vice President and General Manager. Paula was previously Senior Vice President for Cloud, Software, and Managed Services at Cisco.
ILMN: 141.62 (-1.80)
ArcherDX to Collaborate With Illumina on Next-Generation Sequencing Based in Vitro Diagnostics Development
ACCESSWIRE - Tue May 31, 3:57PM CDT
ArcherDX and Illumina will work together to develop and bring multiple Archer® NGS-based IVD assays through the FDA approval process
ILMN: 141.62 (-1.80)
ArcherDX to Collaborate with Illumina on Next-Generation Sequencing-Based In Vitro Diagnostics Development
BusinessWire - Tue May 31, 5:51AM CDT
ArcherDX, Inc. today announced an agreement to develop next-generation sequencing (NGS)-based in vitro diagnostic (IVD) tests with Illumina, Inc. (NASDAQ: ILMN). Under terms of the agreement, ArcherDX will lead the development of a series of diagnostic tests utilizing ArcherDX's Anchored Multiplex PCR (AMP(TM)) chemistry that will be run on the Illumina(R) MiSeqDx(R) instrument. This agreement reflects the commitment of both companies to provide NGS-based diagnostics to support current and future clinical trials.
ILMN: 141.62 (-1.80)
New Strong Sell Stocks for May 26th
Swarup Gupta - Zacks Investment Research - Thu May 26, 9:27AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
CRMT: 24.14 (-0.31), BPY: 24.34 (-0.15), ILMN: 141.62 (-1.80), DXPE: 14.03 (-0.41)
Illumina to Webcast Live Presentation at Upcoming Investment Conferences in June
BusinessWire - Wed May 25, 5:30AM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentation at two upcoming investment conferences.
ILMN: 141.62 (-1.80)
SmarTrend Watching for Potential Rebound in Shares of Illumina After 1.43% Loss
Comtex SmarTrend(R) - Thu May 12, 1:57PM CDT
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $136.15 to a high of $140.15. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $138.64 on volume of 471,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 141.62 (-1.80)
Illumina: Q1 Results Hit by Soaring Costs; '16 View Down
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:28AM CDT
Illumina (ILMN) made a disappointing start to first-quarter 2016 with its top and bottom lines lagging the Zacks Consensus Estimate.
SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06), ILMN: 141.62 (-1.80)
Illumina Registers MiSeqDx System in South Korea
BusinessWire - Mon May 09, 3:05PM CDT
Illumina, Inc. (NASDAQ: ILMN) today announced it has received a product approval certificate for the MiSeqDx(R) Instrument and the MiSeqDx Universal Kit with the Ministry of Food and Drug Safety (MFDS) in South Korea. This successful approval of an Illumina next-generation sequencing (NGS) system is the first step in completing a comprehensive regulatory strategy in the APAC region.
ILMN: 141.62 (-1.80)
Collaborative Study of Whole Exome Sequencing Offers New Hope for Children with White Matter Disorders
BusinessWire - Mon May 09, 7:41AM CDT
Illumina, Inc. (NASDAQ: ILMN), Children's National Health System and The University of Queensland (UQ) announced today that a study using whole exome sequencing (WES), a method to look at all the genes in the genome at once, yielded clinical diagnoses for 42 percent of patients with white matter abnormalities that had been unresolved an average of eight years.
ILMN: 141.62 (-1.80)
